Skip to main content
Fig. 5 | Nutrition & Metabolism

Fig. 5

From: Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis

Fig. 5

Bar charts showing the changes in the different biochemical assays among the experimental groups. a ALT activity, b AST activity, c FINS level, d FBG level; e HOMA-IR, f TG level, g TC level, h LDL-C level, and i HDL-C level. **P < 0.01, vs control group; ##P < 0.01, #P < 0.05, vs HFD group; &P < 0.05, vs OCA group. Data are presented as mean ± standard deviation. n = 8, ALT, alanine aminotransferase; AST, aspartate aminotransferase; FINS, fasting insulin; FBG, fasting blood glucose; HOMA-IR, Homeostatic Model Assessment for Insulin Resistance; TG, triglycerides; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; C, control; HFD, high-fat diet; Gyp, gypenosides; OCA, obeticholic acid

Back to article page